why choose us

First received: December 07, 2023

Clinical Trial: PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Recurrent Non-Muscle Invasive Bladder Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase I Microtrial With PLZ4-Coated Paclitaxel-Loaded Micelles (PPM) in Patients With Recurrent or Refractory Non-Myoinvasive Bladder Cancer

Brief Summary: This phase I trial tests the safety, tolerability and effectiveness of PLZ4-coated paclitacel-loaded micelles (PPM) in treating patients with non-muscle invasive bladder cancer that has come back after a period of improvement (recurrent) or that does not respond to treatment (refractory).PPM is a bladder cancer-specific nanoparticle that can specifically target and deliver treatment to the tumor cells in the bladder.PPM contains paclitaxel, which is a drug that kills tumor cells or keeps them from growing.

Read more